Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker – 4.3)
Index Copernicus  – 171.00; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2016, vol. 25, nr 6, November-December, p. 1215–1221

doi: 10.17219/acem/62919

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Evaluating the Hearing of Patients with Pseudoexfoliation Syndrome

Hanna Temporale1,A,B,C,D, Anna Karasińska-Kłodowska2,A,B,D, Anna Turno-Kręcicka2,A,D,E, Monika Morawska-Kochman1,C,E, Karolina Dorobisz1,B,E, Krzysztof Dudek3,C, Marta Misiuk-Hojło2,B, Tomasz Kręcicki1,A,E

1 Department of ENT, Head and Neck Surgery, Wroclaw Medical University, Poland

2 Department of Ophthalmology, Wroclaw Medical University, Poland

3 Department of Mechanical Engineering, Wrocław University of Technology, Poland

Abstract

Background. It is estimated that pseudoexfoliation syndrome (PEX) occurs in 10–20% of the general population over 60 years of age, and its morbidity increases with age. Some research indicates that PEX may be a systemic disease. Some experts state that it can also lead to ear dysfunction.
Objectives. The aim of the study was to evaluate the incidence and type of hearing disorders in patients with PEX.
Material and Methods. The study included 51 patients (102 eyes) hospitalized in Wroclaw Medical University Hospital’s Department of Ophthalmology and scheduled for cataract surgery in 2012–2014. Among these patients (whose age ranged from 55 to 92), 28 had PEX and 23 served as a control group. Both groups underwent ophtalmic examinations as well as ENT inspection and audiological tests (tonal audiometry, impedance audiometry, distortion product otoacoustic emission tests [DPOAE] and auditory brainstem response tests [ABR]).
Results. A statistically significant increase in the threshold of hearing in pure-tone audiometry was observed in PEX group for 2 kHz. In impedance audiometry tests, the stapedius reflex was identified in a greater proportion of patients in the PEX group than in the control group in all frequency ranges. There was no difference between the PEX groups and the control group in the results of the DPOAE and ABR tests.
Conclusion. PEX can be a systemic disease that affects the functioning of the inner ear causing sensorineural hearing impairment. The increased hearing threshold in pure-tone audiometry of the patients with PEX affects the speech range (mainly the frequency of 2 kHz). Impedance audiometry and pure-tone audiometry appeared useful in audiological diagnostics of patients with PEX.

Key words

hearing, hearing loss, pseudoexfoliation syndrome, presbyacusis

References (28)

  1. Singham NV, Zahari M, Peyman M, Prepageran N, Subrayan V: Association between ocular pseudoexfoliation and sensorineural hearing loss. J Ophthalmol 2014, 825–936.
  2. Elhawy E, Kamthan G, Dong CQ, Danias J: Pseudoexfoliation syndrome, a systemic disorder with ocular manifestations. Hum Genomics 2012, 10, 6–22.
  3. Yazdani S, Tousi A, Pakravan M, Faghihi AR: Sensorineural hearing loss in pseudoexfoliation syndrome. Ophthalmology 2008, 115, 425–429.
  4. Atalar PT, Kilic H, Abbasoglu OE, Ozer N, Aksöyek S, Ovünç K, Ozmen F, Gürsel E: Impaired systemic endothelial function in patients with pseudoeksfoliation syndrome. Int Heart J 2006, 47, 77–84.
  5. Angelilli A, Ritch R: Directed therapy for exfoliation syndrome. Open Ophthalmol J 2009, 17, 3, 70–74.
  6. Astrom S, Linden C: Incidence and prevalence of pseudoexfoliation and open-angle glaucoma in northern Sweden: I. Baseline report. Acta Ophthalmol Scand 2007, 85, 828–831.
  7. Malukiewicz G, Lesiewska-Junk H, Linkowska K: Analysis of LOXL1 single nucleotide polymorphisms in Polish population with pseudoexfoliation syndrome. Acta Ophthalmol 2011, 89, 64–66.
  8. Anastasopoulos E, Founti P, Topouzis F: Update on pseudoexfoliation syndrome pathogenesis and associations with intraocular pressure, glaucoma and systemic diseases. Curr Opin Ophthalmol 2015, 26, 82–89.
  9. Ritch R, Schlötzer-Schrehardt U: Exfoliation syndrome. Surv Ophthalmol 2001, 45, 265–315.
  10. Samarai V, Samarei R, Haghighi N, Jalili E: Sensorineural hearing loss in pseudoexfoliation syndrome. Int J Ophthalmol 2012, 5, 393–396.
  11. Wang W, He M, Zhou M, Zhang X: Ocular pseudoexfoliation syndrome and vascular disease: A systematic review and meta-analysis. PLoS One 2014, 9, 927–967.
  12. Gonen T, Gonen KA, Gumus B: Renal artery stenosis and abdominal aorta aneurysm in patients with pseudoexfoliation syndrome. Eye (Lond) 2013, 27, 735–741.
  13. Ekström C, Kilander L: Pseudoexfoliation and Alzheimer’s disease: A population-based 30 year follow-up study. Acta Ophthalmol 2014, 92, 355–358.
  14. Lim DJ: Functional structure of the organ of Corti: A review. Hear Res 1986, 22, 117–146.
  15. Nash SD, Cruickshanks KJ, Klein R: The prevalence of hearing impairment and associated risk factors: The Beaver Dam Offspring Study. Arch Otolaryngol Head Neck Surg 2011, 137–432.
  16. Jennings CR, Jones NS: Presbyacusis. J Laryngol Otol 2001, 115, 171–178.
  17. Śliwińska-Kowalska M: Audiologia Kliniczna, Mediton, Łódź 2005 [in Polish].
  18. Cahill M, Early A, Stack S, Blayney AW, Eustace P: Pseudoexfoliation and sensorineural hearing loss. Eye (Lond) 2002, 16, 261–266.
  19. Shaban RI, Asfour WM: Ocular pseudoexfoliation associated with hearing loss. Saudi Med J 2004, 25, 1254–1257.
  20. Turacli ME, Ozdemir FA, Tekeli O, Gökcan K, Gerçeker M, Dürük K: Sensorineural hearing loss in pseudoexfoliation. Can J Ophthalmol 2007, 42, 56–59.
  21. Papadopoulos TA, Naxakis SS, Charalabopoulou M, Vathylakis I, Goumas PD, Gartaganis SP: Exfoliation syndrome related to sensorineural hearing loss. Clin Experiment Ophthalmol 2010, 38, 456–461.
  22. Papadopoulos TA, Charalabopoulou M, Vathylakis I, Goumas P, Gartaganis S, Naxakis S: Prevalence and severity of sensorineural hearing loss in patients with exfoliation syndrome. Eur Rev Med Pharmacol Sci 2012, 16, 902–907.
  23. Paliobei VP, Psillas GK, Mikropoulos DG, Haidich AB, Constantinidis J, Konstas AG: Hearing evaluation in patients with exfoliative and primary open-angle glaucoma. Otolaryngol Head Neck Surg 2011, 45, 125–130.
  24. Erbek S, Erbek SS, Karalezli A, Borazan M, Ozlüoğlu LN: Function of outer hair cells in patients with pseudoexfoliation. Kulak Burun Bogaz Ihtis Derg 2009, 19, 130–133.
  25. Huang ZY, Zhou FH, Xie NP, Guo MH, Wan LC, Sun WQ: Clinical analysis of 118 patients with tympanosclerosis. Nan Fang Yi Ke Da Xue Xue Bao 2010, 30, 345–348.
  26. Cagdas KK: The role of experimental myringosclerosis in interpretation of tympanograms and its possible clinical implications. Med Hypotheses 2005, 64, 1132–1134.
  27. Detorakis ET, Chrysochoou F, Paliobei V, Konstas AG, Daniilidis V, Balatsouras D, Kefalidis G, Kozobolis VP: Evaluation of the acoustic function in pseudoexfoliation syndrome and exfoliation glaucoma: Audiometric and tympanometric findings. Eur J Ophthalmol 2008, 18, 71–76.
  28. Mamo SK, Reed NS, Nieman CL, Oh ES, Lin FR: Personal sound amplifiers for adults with hearing loss. Am J Med 2016, 129, 245–250.
© Wroclaw Medical University